Ampio Pharmaceuticals (NYSEAMERICAN:AMPE) Sees Large Volume Increase

Ampio Pharmaceuticals Inc (NYSEAMERICAN:AMPE) saw strong trading volume on Tuesday . 14,091 shares traded hands during mid-day trading, a decline of 98% from the previous session’s volume of 802,884 shares.The stock last traded at $0.42 and had previously closed at $0.40.

A number of hedge funds have recently bought and sold shares of the stock. Courier Capital LLC lifted its stake in shares of Ampio Pharmaceuticals by 7.0% during the 2nd quarter. Courier Capital LLC now owns 379,973 shares of the specialty pharmaceutical company’s stock worth $147,000 after purchasing an additional 25,000 shares during the period. Geode Capital Management LLC increased its holdings in shares of Ampio Pharmaceuticals by 4.4% during the 4th quarter. Geode Capital Management LLC now owns 863,711 shares of the specialty pharmaceutical company’s stock worth $340,000 after buying an additional 36,735 shares during the last quarter. Cypress Capital Management LLC WY increased its holdings in Ampio Pharmaceuticals by 23.1% in the 2nd quarter. Cypress Capital Management LLC WY now owns 288,225 shares of the specialty pharmaceutical company’s stock valued at $112,000 after purchasing an additional 54,000 shares in the last quarter. BlackRock Inc. increased its holdings in Ampio Pharmaceuticals by 1.2% in the 4th quarter. BlackRock Inc. now owns 5,449,616 shares of the specialty pharmaceutical company’s stock valued at $2,152,000 after purchasing an additional 63,190 shares in the last quarter. Finally, LPL Financial LLC acquired a new stake in Ampio Pharmaceuticals in the 2nd quarter valued at $34,000.

Ampio Pharmaceuticals Company Profile (NYSEAMERICAN:AMPE)

Ampio Pharmaceuticals, Inc, a biopharmaceutical company, focuses on the development of therapies for the treatment of prevalent inflammatory conditions in the United States. The company is developing compounds that decrease inflammation by inhibiting specific pro-inflammatory compounds. Its product pipeline includes Ampion, an intra-articular injection for the treatment of osteoarthritis of the knee.

Recommended Story: Elliott Wave Theory

Receive News & Ratings for Ampio Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampio Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.